How do atopic dermatitis trialists perceive the Harmonising Outcomes Measurement in Eczema (HOME) core outcome set? A survey study from the HOME initiative
Yuval Gilad(Tel Aviv University), Yael A. Leshem(Tel Aviv University), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Jochen Schmitt(University Hospital Carl Gustav Carus), Phyllis I. Spuls, Christian Apfelbacher(Heidelberg University), M. E. Jacobson(Oregon Health & Science University), Eric L. Simpson(Oregon Health & Science University), Hywel C Williams(University of Nottingham), Norito Katoh(Kyoto Prefectural University of Medicine), Kim S Thomas(University of Nottingham)
Cited by 2
Related Papers
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2013|1.3k
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..
|British Journal of Dermatology|1994|1.3k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2014|1.2k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892